Donate to support our work
Global Asthma Network Logo Global Asthma Network Global Asthma Network Logo

World Lung Day 2022: Lung Health for All

On World Lung Day, 25 September 2022, the Forum of International Respiratory Societies (FIRS) calls on governments worldwide to address stark global inequalities in respiratory health.

The COVID-19 pandemic may have subsided, but its impact highlights a global lung health crisis that has not gone away.

Read more

Latest GAN Newsletter available

The September 2022 GAN Newsletter is now available on the website. This is our 10 year anniversary Newsletter and includes contributions from our members towards this occasion. In addition, Included in the newsletter are articles on GAN Phase I update, New GAN publications, a FIRS Lung Health facts sheet for World Lung Day, Global Asthma Report update, GAN Centres update and GAN & GAR website usage view newsletter

GAN Asthma Papers published with Editorial

The GAN Asthma Child and adult worldmap papers have been published in the September edition of the European Respiratory Journal. This editorial highlights once again the burden of asthma globally and the importance of monitoring this disease.

Children Worldmap paper | Adult Worldmap paper | Editorial

GAN Rhinitis Paper selected for Editorial

The GAN Rhinitis Time Trends paper as been selected as Editors choice in the February edition of Paediatric Allergy and Immunology. These new global time trends provide important data for the scope and direction of rhinitis strategy.

Article | Editorial

Breaking News: Asthma Time Trends

First publication on asthma prevalence from the GAN Phase I published with open access in The Lancet. These new global asthma time trends provide important data for the scope and direction of asthma strategy. Read more

Article | Commentary | Press Release

2nd International Day of Clean Air for blue skies

7 September is the 2nd International Day of Clean Air for blue skies founded by Global Youth for Clean Air and Climate Health
View Press Release | More info

EAACI-GARD Joint Symposium

EAACI and GARD held a Joint Symposium on July 12th on Chronic Respiratory Diseases in COVID-19 Era.
View Symposium

World Asthma Day 2021

Uncovering Asthma Misconceptions

This year's World Asthma Day theme is "Uncovering Asthma Misconceptions". The theme provides a call to action to address common widely held myths and misconceptions concerning asthma that prevent persons with asthma from enjoying optimal benefit from the major advances in the management of this condition.

Read more

Latest Lung Health Paper published in The Lancet

Jamilah Meghji with other authors including some GAN Steering Group members have published a new paper on Lung Health in LMICs.
View article | Read more

First GAN Surveillance paper published

The first paper from the GAN Phase I surveillance has now been published.
View article | Read more

COVID-19, asthma and other chronic respiratory diseases

Advice for People With Asthma

The Asthma and Allergy Foundation of America has created a comprehensive page of coronavirus information for asthma patients which can be found here

Latest COVID-19 Information

The World Health Organization’s Global Alliance Against Chronic Respiratory Diseases has created this information site covid 19 Dashboard which is kept up to date.


The Global Initiative for Asthma (GINA) has created a page of frequently asked questions regarding asthma management and COVID-19 which can be found here,
and an updated guidance slideset (updated 26/4/2021) here

Global Asthma Report 2018

The Global Asthma Report 2018 was officially launched at the 12th GARD Annual Meeting in Helsinki on 31 August 2018 and is available from
Download the report

Funding and development partners

The Global Asthma Network received major funding from The International Union Against Tuberculosis and Lung Disease (The Union) from 2012-2015. It is also generously supported by funding from the following organisations:

Global Asthma and Allergy Patient Platform
We thank the NIHR Global Health Research Unit on Lung Health and TB in Africa at LSTM - “IMPALA” for helping to make this work possible. In relation to IMPALA (project reference 16/136/35) specifically: IMPALA was funded by the National Institute for Health Research (NIHR) using UK aid from the UK Government to support global health research. The views expressed in this publication are those of the author(s) and not necessarily those of the NIHR or the UK Department of Health and Social Care.
Asthma Australia
Woolcock Institute of Medical Research
Aix Marseille University
Center of Allergy & Immunology, Tbilisi
Riga Stradins University
New Zealand
The Asthma and Respiratory Foundation of New Zealand
Auckland Asthma Charitable Trust
Boehringer Ingelheim
University of Auckland
University of Murcia
Valencia University
Sultanate of Oman
The Oman Respiratory Society
United Kingdom
The London School of Hygiene and Tropical Medicine
St Georges University of London
UK Medical Research Council

Funders of GAN Phase I Centres

Individual centres involved in GAN Phase I data collection were funded by the following organisations:

Argentina, San Francisco
Funded by Dr Héctor Badellino
Brazil, Uruguaiana
Funded by Dr Marilyn Urrutia Pereira
Cameroon, Yaounde
Funded by Elvis Ndikum (95%) and from family, friends (5%)
Costa Rica
Partially funded by an unrestricted grant from Astra Zeneca for logistic purposes
India; Bikaner, Chandigarh, Jaipur, Kolkata, Kottayam, Lucknow, Mysuru, New Delhi, Pune
GAN Phase I was undertaken by Asthma Bhawan in India which was supported by Cipla foundation.
Iran, Karaj
Alborz University of medical Sciences
Kosovo, Gjakova
Municipality of Gjakova and the Directorate for Health and Education
Mexico, all centres
Astra Zeneca and COMPEDIA (Colegio Mexicano de Pediatras Especialistas en Inmunologia Clinica y Alergia) educational grants
Mexico, Puerto Vallarta
Centro Universitario de la Costa, Universidad de Guadalajara
New Zealand, Auckland
Auckland Asthma Charitable Trust
Nicaragua. Managua
Partially funded by an unrestricted grant from Astra Zeneca for logistic purposes
Nigeria, Ibadan
Funded by National Institute for Health Research (NIHR) (IMPALA, grant reference 16/136/35) using UK aid from the UK Government to support global health research
Poland, Katowice
Funded by the Medical University of Silesia
South Africa, Cape Town
Funded by the South African Medical Research Council and by the Allergy Society of South Africa for Heather Zar
Spain, Cartagena, Bilbao, Pamplona
Funded by Instituto de Salud Carlos III
Spain, Cantabria
Funded by Instituto de Investigación Sanitaria Valdecilla (IDIVAL) de Cantabria PRIMVAL 17/01 y 18/01,
Spain, Salamanca
Funded by Gerencia Regional de Salud de la Junta de Castilla y León Sociedad Española de Inmunología Clínica, Alergología y Asma Pediátrica,
Spain, A Coruña
Funded by María José Jove foundation.
Sri Lanka; Anuradhapura, Peradeniya
University of Peradeniya, Peradeniya, Sri Lanka
Syria; Damascus, Lattakia
Damascus: Syrian Private University
Lattakia: Lattakia Medical National Syndicate